Top Story

AF prevalence elevated in women with fewer reproductive years

November 11, 2019
Cardiometabolic Conversations

Weight loss recommended to decrease CV risk in metabolically healthy obesity

Cardiology Today, November 2019
Obesity typically associates with metabolic abnormalities and increased risks for developing CVD and diabetes. However, some individuals have a BMI in the obesity range

New trials elevate focus on polypill strategy for CVD prevention

Cardiology Today, November 2019
Treatment with a polypill — generally combining statins, BP-lowering drugs and sometimes aspirin — is not a new concept for CVD. Two recent successful trials…
In the JournalsPerspective

Insomnia increases CVD risk

November 6, 2019
Symptoms of insomnia, specifically difficulties in falling and staying asleep, early morning awakening and daytime dysfunction, were independent risk factors for the…
More Headlines »

DOAC Reversal: Differences and Applications of Current Agents

This activity is supported by an educational grant from Portola Pharmaceuticals, Inc.

Oral anticoagulation (OAC) is most commonly prescribed for stroke prevention in nonvalvular atrial fibrillation; acute…
More »
Meeting News

VIDEO: Personalized method of LDL estimation enhances analysis of FOURIER

May 6, 2018
More »
Meeting News

VIDEO: PFO closure effectiveness to be tested in real-world population

June 8, 2019
More »